Asia Pacific: China dominates the intranasal drug delivery devices market in Asia Pacific, attributed to the growing geriatric population and increasing awareness about nasal drug delivery. Japan and South Korea are also witnessing substantial growth in the market, supported by advancements in drug delivery technologies.
Europe: The United Kingdom is a major market for intranasal drug delivery devices in Europe, owing to the high prevalence of allergies and respiratory diseases. Germany and France are also key players in the region, spurred by the presence of leading pharmaceutical companies and extensive research and development activities.